
Amgen Corlanor and Sensipar Tablets
Amgen recalls Corlanor and Sensipar tablets over foreign substance contamination.
Stop using the recalled tablets and contact Amgen or your pharmacist for instructions on returning the product and obtaining a replacement or refund.
Why it was recalled
Amgen is recalling Corlanor (ivabradine) tablets, 5 mg, due to the presence of a foreign substance. The recall also includes Sensipar (cinacalcet) tablets in 30 mg, 60 mg, and 90 mg strengths. Consumers should check their medication bottles against the affected NDC codes.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|---|
| Corlanor (ivabradine) tablets | 1138203, 1142065, 2026 | 7.5 mg | NDC 55513-810-60 | D-0615-2026 |
| Corlanor (ivabradine) tablets | 1138901, 2026, 1138201, 1138202, 1138900, 1141143 | 5 mg | NDC 55513-800-99, NDC 55513-800-60 | D-0612-2026 |
| Sensipar (cinacalcet) Tablets | 1157055, 2028 | 60 mg | NDC 55513-074-30 | D-0614-2026 |
| Sensipar (cinacalcet) Tablets | 1156858, 2027 | 30 mg | NDC 55513-073-30 | D-0613-2026 |
| Sensipar (cinacalcet) Tablets | 1157056, 2028 | 90 mg | NDC 55513-075-30 | D-0616-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Foreign Material recalls
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
